Callori Fred 4

What Happened Fred Callori, a director of LeonaBio, was granted an award covering 2,333 shares (reported as a derivative acquisition) on June 23, 2026. The grant is reported at $0.00 per share (no cash paid at grant) and is an outside‑director compensation award, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-23; Form 4 filed 2026-06-24 (timely).
• Transaction type/code: Grant/Award (A); 2,333 derivative shares reported at $0.00.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The award vests on the earlier of (i) June 23, 2027, or (ii) the day before the next annual meeting after June 22, 2026. The grant was pro‑rated under the Issuer’s Outside Director Compensation Policy because Callori joined the board on May 5, 2026.
• Filing timeliness: No late filing indicated.

Context This is a typical outside‑director equity award used as compensation and is subject to vesting; it does not represent an immediate cash purchase or sale. Such grants are common and reflect compensation policy rather than a direct insider market signal. If and when the award vests, tax consequences and any subsequent sale would be reported separately.